CNS Pharmaceuticals (CNSP) Accumulated Expenses (2018 - 2023)
CNS Pharmaceuticals (CNSP) posted Accumulated Expenses of $260,137 for Q2 2023, down 5.9% from $276,573 a year earlier and down 69.5% from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Accumulated Expenses (2018 - 2023) Analysis & Trends
At the end of FY2022, CNS Pharmaceuticals' Accumulated Expenses came in at $828,391, up 268.3% from FY2021.
- Annual Accumulated Expenses shows a four-year compound annual growth rate of 143.4% (FY2018 to FY2022).
- In prior years, CNS Pharmaceuticals' Accumulated Expenses was $224,949 in FY2021 (-56.7%), $519,804 in FY2020, $21,500 in FY2019 (-8.9%) and $23,599 in FY2018.
- Quarterly Accumulated Expenses has run from a low of $21,500 in Q4 2019 to a high of $901,222 in Q3 2021 over five years.
- On a year-over-year basis, Accumulated Expenses increased in three of the last eight quarters, with growth averaging 55.7%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q2 2021, with growth of 587.2%; the weakest was Q3 2022, with a decline of 77.8%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $853,228 (Q1 2023), $828,391 (Q4 2022) and $200,000 (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | CNS Pharmaceuticals | 2.35 Mn | -39.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 260,137.00 |
| Mar 31, 2023 | 853,228.00 |
| Dec 31, 2022 | 828,391.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 276,573.00 |
| Mar 31, 2022 | 307,012.00 |
| Dec 31, 2021 | 224,949.00 |
| Sep 30, 2021 | 901,222.00 |
| Jun 30, 2021 | 760,678.00 |
| Mar 31, 2021 | 534,940.00 |
| Dec 31, 2020 | 519,804.00 |
| Sep 30, 2020 | 260,601.00 |
| Jun 30, 2020 | 110,692.00 |
| Mar 31, 2020 | 144,793.00 |
| Dec 31, 2019 | 21,500.00 |
| Sep 30, 2019 | 46,069.00 |
| Dec 31, 2018 | 23,599.00 |
API Access
CNS Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();